Radiotherapy for neovascular age-related macular degeneration [PDF]
BACKGROUND: Radiotherapy has been proposed as a treatment for new vessel growth in people with neovascular age-related macular degeneration (AMD). OBJECTIVES: To examine the effects of radiotherapy on neovascular AMD. SEARCH METHODS: We searched CENTRAL,
Anders+62 more
core +9 more sources
Pegaptanib for neovascular age-related macular degeneration [PDF]
Purpose To define a minimum set of outcome measures for tracking, comparing, and improving macular degeneration care. Design Recommendations from a working group of international experts in macular degeneration outcomes registry development and patient ...
Adamis, A.P.+6 more
core +9 more sources
Treatment of Neovascular Age Related Macular Degeneration [PDF]
Until the end of the last century, no intervention could alter the natural history of the disease. Only in the last few decades, the retina specialists began to intervene in order to minimize the visual loss in those patients. Last ten years have been especially exciting as the new treatment modalities emerged and for the first time we could not only ...
Nikica Gabric, Ratimir Lazić
core +6 more sources
Deep Learning in Neovascular Age-Related Macular Degeneration [PDF]
Background and objectives: Age-related macular degeneration (AMD) is a complex and multifactorial condition that can lead to permanent vision loss once it progresses to the neovascular exudative stage. This review aims to summarize the use of deep learning in neovascular AMD. Materials and Methods: Pubmed search. Results: Deep learning has demonstrated
Borrelli E+11 more
europepmc +5 more sources
Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study [PDF]
Background Neovascular age-related macular degeneration is a leading cause of sight loss, and early detection and treatment is important. For patients with neovascular age-related macular degeneration in one eye, it is usual practice to monitor the ...
Azuara-Blanco, Augusto+11 more
core +2 more sources
Association of neovascular age-related macular degeneration with migraine [PDF]
AbstractPatients with early onset vascular pathology have been reported to manifest neovascular age-related macular degeneration (AMD). While the blood vessels involved in pathogenesis of migraine remains controversial, it is generally accepted that a major contributor is blood vessel pathology.
Kuang, Tung-Mei+4 more
openaire +4 more sources
Pipeline therapies for neovascular age related macular degeneration [PDF]
AbstractAge related macular degeneration (AMD) is the most common cause of vision loss in the elderly population. Neovascular AMD comprises 10% of all cases and can lead to devastating visual loss due to choroidal neovascularization (CNV). There are various cytokine pathways involved in the formation and leakage from CNV. Prior treatments have included
Peter K. Kaiser, Sruthi Arepalli
openaire +4 more sources
Radiotherapy for neovascular age-related macular degeneration [PDF]
Radiotherapy has been proposed as a treatment to prevent new vessel growth in people with neovascular age-related macular degeneration (AMD).The aim of this review was to examine the effects of radiotherapy on neovascular AMD.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group ...
Evans, JR, Sivagnanavel, V, Chong, V
openaire +5 more sources
Photodynamic therapy for neovascular age-related macular degeneration [PDF]
In neovascular age-related macular degeneration, new vessels grow under the retina, distorting vision and leading to scarring. This is further exacerbated if the blood vessels leak. Photodynamic therapy, originally used in cancer treatment, has been investigated as a way to treat the neovascular membranes without affecting the retina.The aim of this ...
Katherine S Henshaw+3 more
openaire +10 more sources
Mass spectrometry in ocular drug research
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo+6 more
wiley +1 more source